We are live on ! Find out more
SIAU

SB Investment Advisers (UK) Portfolio holdings

AUM $7.73B
1-Year Est. Return 2.35%
This Fund
S&P 500
This Quarter Est. Return
-37.75%
1 Year Est. Return
-2.35%
3 Year Est. Return
+51.59%
5 Year Est. Return
-28.22%
10 Year Est. Return
AUM
$4.56B
AUM Growth
-$2.99B
Cap. Flow
+$951M
Cap. Flow %
20.87%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$951M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 78.71%
2 Healthcare 21.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.86T
$3.59B 78.71%
1,074,980,400
GH icon
2
Guardant Health
GH
$21.7B
$970M 21.29%
+25,816,470
New +$951M

Similar funds

SB Investment Advisers (UK)'s Q4 2018 Portfolio in Review

As of Q4 2018, SB Investment Advisers (UK) held 2 positions worth $4.56B, down 40% from $7.55B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SB Investment Advisers (UK) deployed $951M of net new capital in Q4 2018, opening 1 new position. Its largest new stake was Guardant Health: 25,816,470 shares worth $970M.

By sector, the portfolio is most concentrated in Technology at 79% of assets, down from 100% a quarter earlier, followed by Healthcare.

  • SB Investment Advisers (UK)'s largest Q4 2018 buy was Guardant Health: 25,816,470 shares worth $970M.
  • SB Investment Advisers (UK)'s ten largest holdings make up 100% of its $4.56B portfolio in Q4 2018.
  • SB Investment Advisers (UK) opened 1 new position and closed 0 in Q4 2018.
  • SB Investment Advisers (UK)'s portfolio value fell 40% quarter-over-quarter to $4.56B.

Based on SB Investment Advisers (UK)'s 13F filing for Q4 2018, filed 13 Feb 2019.